Quick Answer
GRI Bio, Inc. reported Total Assets of $8.67 million for the year ending 2025.
- GRI Bio, Inc. showed an increase of +51.0% in Total Assets from 2024 to 2025.
- This data is from GRI Bio, Inc.'s annual report (Form 10-K), filed with the SEC on January 30, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $14.60 million | Q2 2021: $11.65 million | Q3 2021: $10.14 million | Q1 2022: $5.94 million | Q2 2022: $8.01 million | Q3 2022: $5.57 million | Q1 2023: $2.10 million | Q2 2023: $5.64 million | Q3 2023: $4.40 million | Q1 2024: $4.59 million | Q2 2024: $7.03 million | Q3 2024: $5.46 million | Q1 2025: $4.04 million | Q2 2025: $5.68 million | Q3 2025: $4.78 million.
- Over the full 6 years of available data (2020 to 2025), GRI Bio, Inc.'s Total Assets has grown by 807.4%.
- Historical annual values: Fiscal year 2025: $8.67 million | Fiscal year 2024: $5.74 million | Fiscal year 2023: $2.96 million | Fiscal year 2022: $383.0 thousand | Fiscal year 2021: $8.34 million | Fiscal year 2020: $955.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: